Vitaminka announced non-consolidated earnings results for the first quarter ended March 2018. The company’s non-consolidated net profit rose sharply to MKD 22.5 million in the first quarter of 2018 from MKD 5.9 million in the like period of last year. The company's operating revenue edged down to MKD 408.4 million in the first three months of the year from MKD 410.4 million in the same period of 2017. The company’s domestic sales rose 3% on the year to MKD 223.6 million in January-March, while its sales abroad fell 4% year-on-year to MKD 178.5 million.